Free Trial

Sonic Healthcare (OTCMKTS:SKHHY) Sees Large Volume Increase - Should You Buy?

Sonic Healthcare logo with Medical background
Image from MarketBeat Media, LLC.

Key Points

  • Shares traded 49,219 on Friday—down 46% from the prior session’s 91,234—with the stock last at $14.03.
  • Citigroup downgraded Sonic from a "hold" to a "strong sell", and the MarketBeat consensus rating for the stock is "Sell".
  • Technically, the stock is trading below its 50‑day moving average ($15.26) and 200‑day moving average ($14.93), indicating short‑ to medium‑term weakness.
  • MarketBeat previews top five stocks to own in May.

Shares of Sonic Healthcare Ltd. Sponsored ADR (OTCMKTS:SKHHY - Get Free Report) saw strong trading volume on Friday . 49,219 shares traded hands during mid-day trading, a decline of 46% from the previous session's volume of 91,234 shares.The stock last traded at $14.0264 and had previously closed at $14.02.

Wall Street Analysts Forecast Growth

Separately, Citigroup downgraded shares of Sonic Healthcare from a "hold" rating to a "strong sell" rating in a research report on Monday, January 26th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, Sonic Healthcare presently has a consensus rating of "Sell".

View Our Latest Stock Report on SKHHY

Sonic Healthcare Stock Performance

The business's 50-day moving average is $15.26 and its two-hundred day moving average is $14.93.

About Sonic Healthcare

(Get Free Report)

Sonic Healthcare OTCMKTS: SKHHY is a global provider of medical diagnostics services, specializing in pathology and radiology. Established in 1987 and headquartered in Sydney, Australia, the company has grown into one of the largest laboratory networks in the world. Its ordinary shares trade on the Australian Securities Exchange, and its American Depositary Receipts trade over the counter under the symbol SKHHY.

The company offers a broad range of clinical pathology services, including anatomic pathology, clinical chemistry, hematology, microbiology and molecular diagnostics.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Sonic Healthcare Right Now?

Before you consider Sonic Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sonic Healthcare wasn't on the list.

While Sonic Healthcare currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2026 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines